Summary

● In a short-term perspective, the company has interesting fundamentals.


Strengths

● 

● The stock, which is currently worth 2021 to 0.21 times its sales, is clearly overvalued in comparison with peers.

● 

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● 

● 

● 

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.


Weaknesses

● According to forecast, a sluggish sales growth is expected for the next fiscal years.

● 

● Low profitability weakens the company.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 79.39 times its estimated earnings per share for the ongoing year.

● For the past year, analysts have significantly revised downwards their profit estimates.

● 

● The group usually releases earnings worse than estimated.